106 related articles for article (PubMed ID: 19323659)
21. Metformin: a biguanide.
Tanja JJ; Langlass TM
Diabetes Educ; 1995; 21(6):509-10, 513-4. PubMed ID: 8549253
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of once- or twice-daily extended release metformin compared with thrice-daily immediate release metformin in type 2 diabetes mellitus.
Bhansali A; Masoodi SR
J Assoc Physicians India; 2005 May; 53():441-5. PubMed ID: 16124352
[TBL] [Abstract][Full Text] [Related]
23. Medical Treatments of Hidradenitis Suppurativa: More Options, Less Evidence.
van der Zee HH; Gulliver WP
Dermatol Clin; 2016 Jan; 34(1):91-6. PubMed ID: 26617362
[TBL] [Abstract][Full Text] [Related]
24. [40 years of Metformin in the treatment of diabetes mellitus].
Internist (Berl); 1997 Jul; 38(7 Suppl 40 Jahre):1-8. PubMed ID: 9330653
[No Abstract] [Full Text] [Related]
25. Long-term metformin use is associated with decreased risk of breast cancer.
Bodmer M; Meier C; Krähenbühl S; Jick SS; Meier CR
Diabetes Care; 2010 Jun; 33(6):1304-8. PubMed ID: 20299480
[TBL] [Abstract][Full Text] [Related]
26. Treatment with metformin is protective against limitations in instrumental activities of daily living in older subjects with type 2 diabetes mellitus.
Mazziotti G; Bossoni S; Orini S; Salimbeni P; Gazzaruso C; Solerte BS; Vescovi P; Romanelli G; Giustina A
J Am Geriatr Soc; 2009 Mar; 57(3):562-4. PubMed ID: 19278401
[No Abstract] [Full Text] [Related]
27. Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.
Umpierrez G; Issa M; Vlajnic A
Curr Med Res Opin; 2006 Apr; 22(4):751-9. PubMed ID: 16684436
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
[TBL] [Abstract][Full Text] [Related]
29. Metformin in heart failure.
Inzucchi SE; Masoudi FA; McGuire DK
Diabetes Care; 2007 Dec; 30(12):e129. PubMed ID: 18042738
[No Abstract] [Full Text] [Related]
30. [Metformin in the UKPDS study. Metabolic and vascular results].
Basin C; Isnard F
Journ Annu Diabetol Hotel Dieu; 1999; ():243-61. PubMed ID: 10732421
[No Abstract] [Full Text] [Related]
31. Normalization of metabolic syndrome using fenofibrate, metformin or their combination.
Nieuwdorp M; Stroes ES; Kastelein JJ;
Diabetes Obes Metab; 2007 Nov; 9(6):869-78. PubMed ID: 17924869
[TBL] [Abstract][Full Text] [Related]
32. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
[TBL] [Abstract][Full Text] [Related]
33. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
34. Metformin therapy and diabetes in pregnancy.
Simmons D; Walters BN; Rowan JA; McIntyre HD
Med J Aust; 2004 May; 180(9):462-4. PubMed ID: 15115425
[TBL] [Abstract][Full Text] [Related]
35. Metformin plus glyburide combination as therapy in failure to monotherapy in type 2 diabetic patients: one month follow-up.
Medina Santillán R; Reyes-García G; Mateos-García E
Proc West Pharmacol Soc; 2002; 45():139-40. PubMed ID: 12434559
[No Abstract] [Full Text] [Related]
36. The antidiabetic medicine metformin has beneficial effects in hidradenitis suppurativa.
Br J Dermatol; 2023 Nov; 189(6):e111. PubMed ID: 37972134
[No Abstract] [Full Text] [Related]
37. Metformin for the treatment of hidradenitis suppurativa: a little help along the way.
Verdolini R; Clayton N; Smith A; Alwash N; Mannello B
J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1101-8. PubMed ID: 22882365
[TBL] [Abstract][Full Text] [Related]
38. Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab.
Alecsandru D; Padilla B; Izquierdo JA; Fernández-Cruz E; Sánchez-Ramón S
Arch Dermatol; 2010 Dec; 146(12):1343-5. PubMed ID: 21173317
[No Abstract] [Full Text] [Related]
39. The treatment of hidradenitis suppurativa with the glucagon-like peptide-1 agonist liraglutide.
Jennings L; Nestor L; Molloy O; Hughes R; Moriarty B; Kirby B
Br J Dermatol; 2017 Sep; 177(3):858-859. PubMed ID: 27943236
[TBL] [Abstract][Full Text] [Related]
40. Drug survival of metformin in patients with hidradenitis suppurativa.
Senent-Valero M; Matijasevich A; Jara-Rico N; Sivera F; Pascual JC
Br J Dermatol; 2023 Dec; 190(1):125-127. PubMed ID: 37751385
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
